Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

被引：122
|
作者：
Dai, Cong [1 ]
Jiang, Min [1 ]
Sun, Ming-Jun [1 ]
机构：
[1] China Med Univ, Affiliated Hosp 1, Shenyang, Peoples R China
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 377卷 / 05期
关键词：
D O I：
10.1056/NEJMc1707500
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [21] Tofacitinib for ulcerative colitis
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (07): : 475 - 475
  • [22] Tofacitinib in ulcerative colitis
    Archer, Thomas P.
    Moran, Gordon W.
    Ghosh, Subrata
    IMMUNOTHERAPY, 2016, 8 (05) : 495 - 502
  • [23] Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis
    Hyams, Jeffrey
    Damaraju, Lakshmi
    Blank, Marion
    Johanns, Jewel
    Guzzo, Cynthia
    Winter, Harland S.
    Kugathasan, Subra
    Cohen, Stanley
    Markowitz, James
    Escher, Johanna C.
    Veereman-Wauters, Gigi
    Crandall, Wallace
    Baldassano, Robert
    Griffiths, Anne
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (04) : 391 - U169
  • [24] Infliximab induction and maintenance therapy for ulcerative colitis: the act 2 trial
    Sandborn, WJ
    Rachmilewitz, D
    Hanauer, SB
    Lichtenstein, GR
    de Villiers, WJ
    Olson, A
    Johanns, J
    Travers, S
    Colombel, JF
    GASTROENTEROLOGY, 2005, 128 (04) : A36 - A36
  • [25] VEDOLIZUMAB, USTEKINUMAB AND TOFACITINIB AS TRIPLE THERAPY FOR ULCERATIVE COLITIS
    Thurston, Theresa
    Moskow, Joshua
    Glassner, Kerri
    Abraham, Bincy
    GASTROENTEROLOGY, 2023, 164 (04) : S104 - S104
  • [26] VEDOLIZUMAB, USTEKINUMAB AND TOFACITINIB AS TRIPLE THERAPY FOR ULCERATIVE COLITIS
    Thurston, Theresa
    Moskow, Joshua
    Glassner, Kerri
    Abraham, Bincy
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S81 - S81
  • [27] Janus Kinase Inhibitor Tofacitinib for Induction and Remission in ulcerative colitis
    Sandborn, W. J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (14) : 1022 - 1023
  • [28] Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis
    Sandborn, William J.
    Peyrin-Biroulet, Laurent
    Quirk, Daniel
    Wang, Wenjin
    Nduaka, Chudy, I
    Mukherjee, Arnab
    Su, Chinyu
    Sands, Bruce E.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (08) : 1821 - +
  • [29] EFFICACY OF TOFACITINIB MAINTENANCE THERAPY FOR ULCERATIVE COLITIS IN REMITTING PATIENTS VS PATIENTS WITH CLINICAL RESPONSE AFTER 8 WEEKS OF INDUCTION TREATMENT
    Reinisch, Walter
    Osterman, Mark T.
    Doherty, Glen
    Marren, Amy
    Woodworth, Deborah A.
    Lawendy, Nervin
    Kwok, Kenneth
    Maller, Eric S.
    Su, Chinyu
    GASTROENTEROLOGY, 2019, 156 (06) : S1098 - S1098
  • [30] Prebiotics for induction and maintenance of remission in ulcerative colitis
    Sinopoulou, Vassiliki
    Gordon, Morris
    Gregory, Vicki
    Saadeh, Anas
    Akobeng, Anthony K.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (03):
12345